Bo-wen Lin

Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.

Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.

Journal: Therapeutic advances in medical oncology
Published: February 02, 2026

Clinical and immunological implications of lymphocyte-activation gene 3 expression in metastatic colorectal cancer.

Clinical and immunological implications of lymphocyte-activation gene 3 expression in metastatic colorectal cancer.

Journal: Cancer immunology, immunotherapy : CII
Published: November 07, 2025

Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world study.

Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world study.

Journal: American journal of cancer research
Published: June 04, 2025

Transcutaneous auricular vagus nerve stimulation accelerates postoperative ileus recovery by enhancing gastric motility complexity: A clinical study.

Transcutaneous auricular vagus nerve stimulation accelerates postoperative ileus recovery by enhancing gastric motility complexity: A clinical study.

Journal: Brain stimulation
Published: April 14, 2025

Evolution of surgical trends in Crohn's disease during the biologic era: population-based cohort insights from Taiwan, a low-endemicity region.

Evolution of surgical trends in Crohn's disease during the biologic era: population-based cohort insights from Taiwan, a low-endemicity region.

Journal: Intestinal research
Published: January 10, 2025

Targeting NUDT21-mediated alternative polyadenylation of oncogenes ameliorates colorectal cancer malignancy and metastasis.

Targeting NUDT21-mediated alternative polyadenylation of oncogenes ameliorates colorectal cancer malignancy and metastasis.

Journal: British journal of cancer
Published: January 07, 2025

Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer.

Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer.

Journal: American journal of cancer research
Published: October 07, 2024

Increased resting heart rate indicates high-workload hearts with augmented aortic hydraulic power in hypertensive pigs.

Increased resting heart rate indicates high-workload hearts with augmented aortic hydraulic power in hypertensive pigs.

Journal: PloS one
Published: June 08, 2024

Overexpression of NUDT16L1 sustains proper function of mitochondria and leads to ferroptosis insensitivity in colorectal cancer.

Overexpression of NUDT16L1 sustains proper function of mitochondria and leads to ferroptosis insensitivity in colorectal cancer.

Journal: Redox biology
Published: April 29, 2024

Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registry.

Survival benefit of metastasectomy in first-line cetuximab therapy in patients with RAS wild-type metastatic colorectal cancer: a nationwide registry.

Journal: American journal of cancer research
Published: September 13, 2023

Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity.

Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity.

Journal: Cell death & disease
Published: August 03, 2023

Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.

Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.

Journal: Nutrients
Published: May 27, 2023
Showing 1-12 of 46

Last Updated: 09/26/2026